ABUS vs BR
Arbutus Biopharma Corp (ABUS) versus Broadridge Financial Solutions Inc (BR) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Not investment advice. Open the ABUS and BR stock pages for the full models.
Not investment advice.